Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases
Abstract
:1. Introduction
2. Traditional Indian Medicine
2.1. Ayurveda
2.2. Siddha System
2.3. Unani System
2.4. Homeopathy
2.5. Yoga
2.6. Naturopathy
3. Traditional Chinese Medicine
4. Miscellaneous Natural Products
4.1. Curcumin
4.2. Elderberry (Sambucus nigra)
4.3. Glutathione
4.4. Medical Mushrooms
4.5. Astaxanthin
4.6. Andrographis paniculata
4.7. Propolis
4.8. Probiotics
4.9. N-Acetyl Cysteine (NAC)
4.10. Quercetin
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ng, T.I.; Correia, I.; Seagal, J.; DeGoey, D.A.; Schrimpf, M.R.; Hardee, D.J.; Noey, E.L.; Kati, W.M. Antiviral Drug Discovery for the Treatment of COVID-19 Infections. Viruses 2022, 14, 961. [Google Scholar] [CrossRef] [PubMed]
- Nicholson, L.B. The immune system. Essays Biochem. 2016, 60, 275–301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Soleymani, S.; Naghizadeh, A.; Karimi, M.; Zarei, A.; Mardi, R.; Kordafshari, G.; Esmaealzadeh, N.; Zargaran, A. COVID-19: General Strategies for Herbal Therapies. J. Evid. Based Integr. Med. 2022, 27, 2515690X211053641. [Google Scholar] [CrossRef] [PubMed]
- Gombart, A.F.; Pierre, A.; Maggini, S. A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection. Nutrients 2020, 12, 236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wieland, L.S.; Piechotta, V.; Feinberg, T.; Ludeman, E.; Hutton, B.; Kanji, S.; Seely, D.; Garritty, C. Elderberry for prevention and treatment of viral respiratory illnesses: A systematic review. BMC Complement. Med. Ther. 2021, 21, 112. [Google Scholar] [CrossRef]
- Freckelton, I. COVID-19: Fear, quackery, false representations and the law. Int. J. Law Psychiatry 2020, 72, 101611. [Google Scholar] [CrossRef] [PubMed]
- Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules 2016, 21, 559. [Google Scholar] [CrossRef] [Green Version]
- Calixto, J.B. The role of natural products in modern drug discovery. An. Da Acad. Bras. De Cienc. 2019, 91 (Suppl. 3), e20190105. [Google Scholar] [CrossRef] [PubMed]
- Loguercio, C.; Festi, D. Silybin and the liver: From basic research to clinical practice. World J. Gastroenterol. 2011, 17, 2288–2301. [Google Scholar] [CrossRef] [PubMed]
- Atanasov, A.G.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Linder, T.; Wawrosch, C.; Uhrin, P.; Temml, V.; Wang, L.; Schwaiger, S.; Heiss, E.H.; et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015, 33, 1582–1614. [Google Scholar] [CrossRef]
- Negi, A.S.; Kumar, J.K.; Luqman, S.; Shanker, K.; Gupta, M.M.; Khanuja, S.P. Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads. Med. Res. Rev. 2008, 28, 746–772, published correction appears in Med. Res. Rev. 2008, 28, 821. [Google Scholar] [CrossRef] [PubMed]
- Girish, C.; Pradhan, S.C. Drug development for liver diseases: Focus on picroliv, ellagic acid and curcumin. Fundam. Clin. Pharmacol. 2008, 22, 623–632. [Google Scholar] [CrossRef] [PubMed]
- Chandran, H.; Meena, M.; Barupal, T.; Sharma, K. Plant tissue culture as a perpetual source for production of industrially important bioactive compounds. Biotechnol. Rep. 2020, 26, e00450. [Google Scholar] [CrossRef]
- Yeshi, K.; Crayn, D.; Ritmejerytė, E.; Wangchuk, P. Plant Secondary Metabolites Produced in Response to Abiotic Stresses Has Potential Application in Pharmaceutical Product Development. Molecules 2022, 27, 313. [Google Scholar] [CrossRef] [PubMed]
- Pye, C.R.; Bertin, M.J.; Lokey, R.S.; Gerwick, W.H.; Linington, R.G. Retrospective analysis of natural products provides insights for future discovery trends. Proc. Natl. Acad. Sci. USA 2017, 114, 5601–5606. [Google Scholar] [CrossRef] [Green Version]
- Pandey, M.M.; Rastogi, S.; Rawat, A.K. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid. Based Complement. Altern. Med. 2013, 2013, 376327. [Google Scholar] [CrossRef] [Green Version]
- Sen, S.; Chakraborty, R. Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future. J. Tradit. Complement. Med. 2016, 7, 234–244. [Google Scholar] [CrossRef]
- Mishra, A.; Bentur, S.A.; Thakral, S.; Garg, R.; Duggal, B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: A case report. J. Med. Case Rep. 2021, 15, 95. [Google Scholar] [CrossRef]
- Kessler, C.; Wischnewsky, M.; Michalsen, A.; Eisenmann, C.; Melzer, J. Ayurveda: Between religion, spirituality, and medicine. Evid. Based Complement. Altern. Med. 2013, 2013, 952432. [Google Scholar] [CrossRef]
- Ragozin, B.V. The history of the development of Ayurvedic medicine in Russia. Anc. Sci. Life 2016, 35, 143–149. [Google Scholar] [CrossRef]
- Warrier, M. Seekership, Spirituality and Self-Discovery: Ayurveda Trainees in Britain. Asian Med. 2009, 4, 423–451. [Google Scholar] [CrossRef] [Green Version]
- Pan, S.Y.; Litscher, G.; Gao, S.H.; Zhou, S.F.; Yu, Z.L.; Chen, H.Q.; Zhang, S.F.; Tang, M.K.; Sun, J.N.; Ko, K.M. Historical perspective of traditional indigenous medical practices: The current renaissance and conservation of herbal resources. Evid. Based Complement. Altern. Med. 2014, 2014, 525340. [Google Scholar] [CrossRef] [Green Version]
- Patwardhan, B.; Warude, D.; Pushpangadan, P.; Bhatt, N. Ayurveda and traditional Chinese medicine: A comparative overview. Evid. Based Complement. Altern. Med. 2005, 2, 465–473. [Google Scholar] [CrossRef] [Green Version]
- Jaiswal, Y.S.; Williams, L.L. A glimpse of Ayurveda—The forgotten history and principles of Indian traditional medicine. J. Tradit. Complement. Med. 2017, 7, 50–53. [Google Scholar] [CrossRef]
- Telles, S.; Pathak, S.; Kumar, A.; Mishra, P.; Balkrishna, A. Ayurvedic doshas as predictors of sleep quality. Med. Sci. Monit. 2015, 21, 1421–1427. [Google Scholar] [CrossRef] [Green Version]
- Ravishankar, B.; Shukla, V.J. Indian systems of medicine: A brief profile. Afr. J. Tradit. Complement. Altern. Med. 2007, 4, 319–337. [Google Scholar] [CrossRef] [Green Version]
- Hausman, G.J. Dimensions of Authenticity in Siddha Medical and Clinical Research. Asian Med. 2022, 17, 115–147. [Google Scholar] [CrossRef]
- Thas, J.J. Siddha medicine—Background and principles and the application for skin diseases. Clin. Dermatol. 2008, 26, 62–78. [Google Scholar] [CrossRef]
- Poulakou-Rebelakou, E.; Karamanou, M.; George, A. The impact of ancient Greek medicine in India: The birth of Unani medicine. Acta Med. Hist. Adriat. 2015, 13, 323–328. [Google Scholar]
- Sana, S.H. Holistic Approach of Unani Medicine: Integrating Basic Concepts of Unani Medicine and Health Perspective. Int. J. Res. Rev. 2019, 6, 63–66. [Google Scholar]
- Jabin, F. A guiding tool in Unani Tibb for maintenance and preservation of health: A review study. Afr. J. Tradit. Complement. Altern. Med. 2011, 8 (Suppl. 5), 140–143. [Google Scholar] [CrossRef] [PubMed]
- Ansari, A.P.; Ahmed, Z.N.; Wadud, A.; Arif, M.; Khanday, S. Ilaj bil Ghiza (Dietotherapy): A core mode of Unani treatment. J. Adv. Res. Pharm. Sci. Pharmacol. Interv. 2018, 2, 27–35. [Google Scholar]
- Ansari, A.P. ’Ilāj bi’l-Tadbīr (regimenal therapy): A core mode of Unani treatment. J. Complement. Integr. Med. 2020, 18, 449–458. [Google Scholar] [CrossRef]
- Ghosh, A.K. A short history of the development of homeopathy in India. Homeopathy 2010, 99, 130–136. [Google Scholar] [CrossRef]
- Loudon, I. A brief history of homeopathy. J. R. Soc. Med. 2006, 99, 607–661. [Google Scholar] [CrossRef] [Green Version]
- Field, T. Yoga research review. Complement. Ther. Clin. Pract. 2016, 24, 145–161. [Google Scholar] [CrossRef] [PubMed]
- Cramer, H.; Ward, L.; Steel, A.; Lauche, R.; Dobos, G.; Zhang, Y. Prevalence, Patterns, and Predictors of Yoga Use: Results of a U.S. Nationally Representative Survey. Am. J. Prev. Med. 2016, 50, 230–235. [Google Scholar] [CrossRef] [PubMed]
- Park, C.L.; Braun, T.; Siegel, T. Who practices yoga? A systematic review of demographic, health-related, and psychosocial factors associated with yoga practice. J. Behav. Med. 2015, 38, 460–471. [Google Scholar] [CrossRef] [PubMed]
- Horrigan, B.; Lewis, S.; Abrams, D.I.; Pechura, C. Integrative Medicine in America—How Integrative Medicine Is Being Practiced in Clinical Centers Across the United States. Glob. Adv. Health Med. 2012, 1, 18–94. [Google Scholar] [CrossRef] [Green Version]
- Fleming, S.A.; Gutknecht, N.C. Naturopathy and the primary care practice. Prim. Care. 2010, 37, 119–136. [Google Scholar] [CrossRef] [Green Version]
- Tabish, S.A. Complementary and Alternative Healthcare: Is it Evidence-based? Int. J. Health Sci. 2008, 2, 5–9. [Google Scholar]
- Galeazzi, R.L. Unerwünschte Wirkungen von Naturheilmitteln [Adverse reactions to natural remedies]. Ther. Umsch. 1992, 49, 86–92. [Google Scholar] [PubMed]
- Kaye, A.D.; Okeagu, C.N.; Pham, A.D.; Silva, R.A.; Hurley, J.J.; Arron, B.L.; Sarfraz, N.; Lee, H.N.; Ghali, G.E.; Gamble, J.W.; et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract. Res. Clin. Anaesthesiol. 2021, 35, 293–306. [Google Scholar] [CrossRef]
- Umesh, C.; Ramakrishna, K.K.; Jasti, N.; Bhargav, H.; Varambally, S. Role of Ayurveda and Yoga-Based lifestyle in the COVID-19 pandemic - A narrative review. J. Ayurveda Integr. Med. 2022, 13, 100493. [Google Scholar] [CrossRef] [PubMed]
- Joseph, S.M.; Iyer, D.S.; Pillai, R.V. Ayurvedic Response to COVID-19 Pandemic in Kerala, India and Its Impact on Quarantined Individuals—A Community Case Study. Front. Public Health 2021, 9, 732523. [Google Scholar] [CrossRef]
- Girija, P.; Sivan, N. Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report. J. Ayurveda Integr. Med. 2020, 13, 100329. [Google Scholar]
- Maurya, V.K.; Kumar, S.; Prasad, A.K.; Bhatt, M.; Saxena, S.K. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease 2020, 31, 179–193. [Google Scholar] [CrossRef] [PubMed]
- Tillu, G.; Salvi, S.; Patwardhan, B. AYUSH for COVID-19 management. J. Ayurveda Integr. Med. 2020, 11, 95–96. [Google Scholar] [CrossRef]
- Yashin, A.; Yashin, Y.; Xia, X.; Nemzer, B. Antioxidant Activity of Spices and Their Impact on Human Health: A Review. Antioxidants 2017, 6, 70. [Google Scholar] [CrossRef] [Green Version]
- Khanna, K.; Kohli, S.K.; Kaur, R.; Bhardwaj, A.; Bhardwaj, V.; Ohri, P.; Sharma, A.; Ahmad, A.; Bhardwaj, R.; Ahmad, P. Herbal immune-boosters: Substantial warriors of pandemic COVID-19 battle. Phytomedicine 2021, 85, 153361. [Google Scholar] [CrossRef] [PubMed]
- Xu, J.; Xia, Z. Traditional Chinese Medicine (TCM)—Does its contemporary business booming and globalization really reconfirm its medical efficacy & safety? Med. Drug Discov. 2019, 1, 100003. [Google Scholar] [CrossRef]
- Ma, Y.; Chen, M.; Guo, Y.; Liu, J.; Chen, W.; Guan, M.; Wang, Y.; Zhao, X.; Wang, X.; Li, H.; et al. Prevention and treatment of infectious diseases by traditional Chinese medicine: A commentary. Acta Pathol. Microbiol. Immunol. Scand. 2019, 127, 372–384. [Google Scholar] [CrossRef] [Green Version]
- Lu, A.P.; Jia, H.W.; Xiao, C.; Lu, Q.P. Theory of traditional Chinese medicine and therapeutic method of diseases. World J. Gastroenterol. 2004, 10, 1854–1856. [Google Scholar] [CrossRef]
- Chung, S.; Cha, S.; Lee, S.Y.; Park, J.H.; Lee, S. The five elements of the cell. Integr. Med. Res. 2017, 6, 452–456. [Google Scholar] [CrossRef]
- Fang, J.; Zheng, N.; Wang, Y.; Cao, H.; Sun, S.; Dai, J.; Li, Q.; Zhang, Y. Understanding Acupuncture Based on Evidence-Based ZHENG: A Traditional Chinese Medicine Syndrome 2013. Evid Based Complement Altern. Med. 2014, 2014, 484201. [Google Scholar] [CrossRef]
- Dai, J.; Sun, S.; Cao, H.; Zheng, N.; Wang, W.; Gou, X.; Su, S.; Zhang, Y. Applications of New Technologies and New Methods in ZHENG Differentiation. Evid. Based Complement. Alternat. Med. 2012, 2012, 298014. [Google Scholar] [CrossRef] [Green Version]
- Xi, S.; Li, Y.; Yue, L.; Gong, Y.; Qian, L.; Liang, T.; Ye, Y.A. Role of Traditional Chinese Medicine in the Management of Viral Pneumonia. Front. Pharmacol. 2020, 11, 582322. [Google Scholar] [CrossRef]
- Wang, T.; Dong, J. What is “zheng” in traditional Chinese medicine? J. Tradit. Chin. Med. Sci. 2017, 4, 14–15. [Google Scholar] [CrossRef]
- Luiz, A.B.; Cordovil, I.; Filho, J.B.; Ferreira, A.S. Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension. Chin. Med. 2011, 6, 23. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Qiu, T.; Liang, S.; Dabbous, M.; Wang, Y.; Han, R.; Toumi, M. Chinese guidelines related to novel coronavirus pneumonia. J. Mark. Access Health Policy 2020, 8, 1818446. [Google Scholar] [CrossRef]
- Ren, X.; Shao, X.X.; Li, X.X.; Jia, X.H.; Song, T.; Zhou, W.Y.; Wang, P.; Li, Y.; Wang, X.L.; Cui, Q.H.; et al. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. J. Ethnopharmacol. 2020, 258, 112932. [Google Scholar] [CrossRef]
- Ni, L.; Chen, L.; Huang, X.; Han, C.; Xu, J.; Zhang, H.; Luan, X.; Zhao, Y.; Xu, J.; Yuan, W.; et al. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm. Sin. B 2020, 10, 1149–1162. [Google Scholar] [CrossRef]
- Zhao, F.; Yang, Z.; Wang, N.; Jin, K.; Luo, Y. Traditional Chinese Medicine and Western Medicine Share Similar Philosophical Approaches to Fight COVID-19. Aging Dis. 2021, 12, 1162–1168. [Google Scholar] [CrossRef]
- Lyu, M.; Fan, G.; Xiao, G.; Wang, T.; Xu, D.; Gao, J.; Ge, S.; Li, Q.; Ma, Y.; Zhang, H.; et al. Traditional Chinese medicine in COVID-19. Acta Pharm. Sin. B 2021, 11, 3337–3363. [Google Scholar] [CrossRef]
- Sharifi-Rad, J.; Rayess, Y.E.; Rizk, A.A.; Sadaka, C.; Zgheib, R.; Zam, W.; Sestito, S.; Rapposelli, S.; Neffe-Skocińska, K.; Zielińska, D.; et al. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front. Pharmacol. 2020, 11, 01021. [Google Scholar] [CrossRef]
- Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharmacol. 2017, 174, 1325–1348. [Google Scholar] [CrossRef] [Green Version]
- Adamczak, A.; Ożarowski, M.; Karpiński, T.M. Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals 2020, 13, 153. [Google Scholar] [CrossRef]
- Dosoky, N.S.; Setzer, W.N. Chemical Composition and Biological Activities of Essential Oils of Curcuma Species. Nutrients 2018, 10, 1196. [Google Scholar] [CrossRef] [Green Version]
- Quispe, C.; Herrera-Bravo, J.; Javed, Z.; Khan, K.; Raza, S.; Gulsunoglu-Konuskan, Z.; Daştan, S.D.; Sytar, O.; Martorell, M.; Sharifi-Rad, J.; et al. Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective. BioMed Res. Int. 2022, 2022, 1375892. [Google Scholar] [CrossRef]
- Patel, S.S.; Acharya, A.; Ray, R.S.; Agrawal, R.; Raghuwanshi, R.; Jain, P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit. Rev. Food Sci. Nutr. 2020, 60, 887–939. [Google Scholar] [CrossRef]
- Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. The Essential Medicinal Chemistry of Curcumin. J. Med. Chem. 2017, 60, 1620–1637. [Google Scholar] [CrossRef] [PubMed]
- Hu, J.; Teng, J.; Wang, W.; Yang, N.; Tian, H.; Zhang, W.; Peng, X.; Zhang, J. Clinical efficacy and safety of traditional Chinese medicine Xiao Yao San in insomnia combined with anxiety. Medicine 2021, 100, e27608. [Google Scholar] [CrossRef] [PubMed]
- Bormann, M.; Alt, M.; Schipper, L.; van de Sand, L.; Le-Trilling, V.T.K.; Rink, L.; Heinen, N.; Madel, R.J.; Otte, M.; Wuensch, K.; et al. Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro. Viruses 2021, 13, 1914. [Google Scholar] [CrossRef]
- Pawar, K.S.; Mastud, R.N.; Pawar, S.K.; Pawar, S.S.; Bhoite, R.R.; Bhoite, R.R.; Kulkarni, M.V.; Deshpande, A.R. Oral Curcumin with Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial. Front. Pharmacol. 2021, 12, 669362. [Google Scholar] [CrossRef] [PubMed]
- Sharma, V.K.; Prateeksha; Singh, S.P.; Singh, B.N.; Rao, C.V.; Barik, S.K. Nanocurcumin Potently Inhibits SARS-CoV-2 Spike Protein-Induced Cytokine Storm by Deactivation of MAPK/NF-κB Signaling in Epithelial Cells. ACS Appl. Biomater. 2022, 5, 483–491. [Google Scholar] [CrossRef]
- Młynarczyk, K.; Walkowiak-Tomczak, D.; Łysiak, G.P. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry. J. Funct. Foods 2018, 40, 377–390. [Google Scholar] [CrossRef]
- Marțiș, G.S.; Mureșan, V.; Marc, R.M.; Mureșan, C.C.; Pop, C.R.; Buzgău, G.; Mureșan, A.E.; Ungur, R.A.; Muste, S. The Physicochemical and Antioxidant Properties of Sambucus nigra L. and Sambucus nigra Haschberg during Growth Phases: From Buds to Ripening. Antioxidants 2021, 10, 1093. [Google Scholar] [CrossRef]
- Perkins-Veazie, P.; Thomas, A.L.; Byers, P.L.; Finn, C.E. Fruit Composition of Elderberry (Sambucus spp.) Genotypes Grown in Oregon and Missouri, USA. Acta Hortic. 2015, 1061, 219–224. [Google Scholar] [CrossRef] [Green Version]
- Vulić, J.; Vračar, L.; Šumić, Z. Chemical characterictics of cultivated elderberry fruit. Acta Period. Technol. 2008, 39, 85–90. [Google Scholar] [CrossRef]
- Ferreira, S.S.; Silva, P.; Silva, A.M.; Nunes, F.M. Effect of harvesting year and elderberry cultivar on the chemical composition and potential bioactivity: A three-year study. Food Chem. 2020, 302, 125366. [Google Scholar] [CrossRef]
- Tiralongo, E.; Wee, S.S.; Lea, R.A. Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients 2016, 8, 182. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sidor, A.; Gramza-Michalowska, A. Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food—A review. J. Funct. Foods 2015, 18, 941–958. [Google Scholar] [CrossRef]
- Hawkins, J.; Baker, C.; Cherry, L.; Dunne, E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials. Complement. Ther. Med. 2019, 42, 361–365. [Google Scholar] [CrossRef] [PubMed]
- Fink, R.C.; Roschek, B., Jr.; Alberte, R.S. HIV type-1 entry inhibitors with a new mode of action. Antivir. Chem. Chemother. 2009, 19, 243–255. [Google Scholar] [CrossRef] [Green Version]
- Putra, W.E.; Rifa’i, M. Immunomodulatory Activities of Sambucus javanica Extracts in DMBA-Exposed BALB/c Mouse. Adv. Pharm. Bull. 2019, 9, 619–623. [Google Scholar] [CrossRef]
- Ulbricht, C.; Basch, E.; Cheung, L.; Goldberg, H.; Hammerness, P.; Isaac, R.; Khalsa, K.P.; Romm, A.; Rychlik, I.; Varghese, M.; et al. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2014, 11, 80–120. [Google Scholar] [CrossRef]
- Avan, A.; Postma, T.J.; Ceresa, C.; Avan, A.; Cavaletti, G.; Giovannetti, E.; Peters, G.J. Platinum-induced neurotoxicity and preventive strategies: Past, present, and future. Oncologist 2015, 20, 411–432. [Google Scholar] [CrossRef] [Green Version]
- Mitchell, J.B.; Russo, A. The role of glutathione in radiation and drug induced cytotoxicity. Br. J. Cancer 1987, 8, 96–104. [Google Scholar]
- Grey, V.; Mohammed, S.R.; Smountas, A.A.; Bahlool, R.; Lands, L.C. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J. Cyst. Fibros. 2003, 2, 195–198. [Google Scholar] [CrossRef] [Green Version]
- Narayanankutty, A.; Job, J.T.; Narayanankutty, V. Glutathione, an Antioxidant Tripeptide: Dual Roles in Carcinogenesis and Chemoprevention. Curr. Protein Pept. Sci. 2019, 20, 907–917. [Google Scholar] [CrossRef]
- Lushchak, V.I. Glutathione homeostasis and functions: Potential targets for medical interventions. J. Amino Acids 2012, 2012, 736837. [Google Scholar] [CrossRef] [Green Version]
- Burgess, J.R.; Yang, H.; Chang, M.; Rao, M.K.; Tu, C.P.; Reddy, C.C. Enzymatic transformation of PGH2 to PGF2 alpha catalyzed by glutathione S-transferases. Biochem. Biophys. Res. Commun. 1987, 142, 441–447. [Google Scholar] [CrossRef]
- Linani, A.; Benarous, K.; Bou-Salah, L.; Yousfi, M.; Goumri-Said, S. Exploring Structural Mechanism of COVID-19 Treatment with Glutathione as a Potential Peptide Inhibitor to the Main Protease: Molecular Dynamics Simulation and MM/PBSA Free Energy Calculations Study. Int. J. Pept. Res. Ther. 2022, 28, 55. [Google Scholar] [CrossRef] [PubMed]
- Lana, J.F.S.D.; Lana, A.V.S.D.; Rodrigues, Q.S.; Santos, G.S.; Navani, R.; Navani, A.; da Fonseca, L.F.; Azzini, G.O.M.; Setti, T.; Mosaner, T.; et al. Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset. Adv. Redox Res. 2021, 3, 100015. [Google Scholar] [CrossRef] [PubMed]
- Ghezzi, P. Role of glutathione in immunity and inflammation in the lung. Int. J. Gen. Med. 2011, 4, 105–113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Polonikov, A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infect. Dis. 2020, 6, 1558–1562. [Google Scholar] [CrossRef]
- Silvagno, F.; Vernone, A.; Pescarmona, G.P. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants 2020, 9, 624. [Google Scholar] [CrossRef]
- Anusiya, G.; Gowthama Prabu, U.; Yamini, N.V.; Sivarajasekar, N.; Rambabu, K.; Bharath, G.; Banat, F. A review of the therapeutic and biological effects of edible and wild mushrooms. Bioengineered 2021, 12, 11239–11268. [Google Scholar] [CrossRef] [PubMed]
- Valverde, M.E.; Hernández-Pérez, T.; Paredes-López, O. Edible mushrooms: Improving human health and promoting quality life. Int. J. Microbiol. 2015, 2015, 376387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, L.; Li, J.Q.; Zhang, J.; Li, Z.M.; Liu, H.G.; Wang, Y.Z. Traditional uses, chemical components and pharmacological activities of the genus Ganoderma, P. Karst.: A review. RSC Adv. 2020, 10, 42084–42097. [Google Scholar] [CrossRef]
- Sande, D.; Oliveira, G.P.; Moura, M.A.F.E.; Martins, B.A.; Lima, M.T.N.S.; Takahashi, J.A. Edible mushrooms as a ubiquitous source of essential fatty acids. Food Res. Int. 2019, 125, 108524. [Google Scholar] [CrossRef]
- Muszyńska, B.; Grzywacz-Kisielewska, A.; Kała, K.; Gdula-Argasińska, J. Anti-inflammatory properties of edible mushrooms: A review. Food Chem. 2018, 243, 373–381. [Google Scholar] [CrossRef] [PubMed]
- Rajewska, J.; Bałasińska, B. Biologically active compounds of edible mushrooms and their beneficial impact on health. Postep. Hig. I Med. Dosw. 2004, 58, 352–357. [Google Scholar]
- Sima, P.; Vannucci, L.; Vetvicka, V. β-glucans and cholesterol (Review). Int. J. Mol. Med. 2018, 41, 1799–1808. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vetvicka, V.; Teplyakova, T.V.; Shintyapina, A.B.; Korolenko, T.A. Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression. J. Fungi 2021, 7, 250. [Google Scholar] [CrossRef] [PubMed]
- Ayaz, F.A.; Chuang, L.T.; Torun, H.; Colak, A.; Sesli, E.; Presley, J.; Smith, B.R.; Glew, R.H. Fatty acid and amino acid compositions of selected wild-edible mushrooms consumed in Turkey. Int. J. Food Sci. Nutr. 2011, 62, 328–335. [Google Scholar] [CrossRef] [PubMed]
- Sharma, D.; Singh, V.P.; Singh, N.K. A Review on Phytochemistry and Pharmacology of Medicinal as well as Poisonous Mushrooms. Mini Rev. Med. Chem. 2018, 18, 1095–1109. [Google Scholar] [CrossRef] [PubMed]
- Coelho, L.C.B.B.; Silva, P.M.D.S.; Lima, V.L.D.M.; Pontual, E.V.; Paiva, P.M.G.; Napoleao, T.H.; Correia, M.T.D.S. Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications. Evid. Based Complement. Alternat. Med. 2017, 2017, 1594074. [Google Scholar] [CrossRef] [PubMed]
- Fontes, A.; Alemany-Pagès, M.; Oliveira, P.J.; Ramalho-Santos, J.; Zischka, H.; Azul, A.M. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. Int. J. Mol. Sci. 2019, 20, 3987. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wińska, K.; Mączka, W.; Gabryelska, K.; Grabarczyk, M. Mushrooms of the Genus Ganoderma Used to Treat Diabetes and Insulin Resistance. Molecules 2019, 24, 4075. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ganeshpurkar, A.; Rai, G.; Jain, A.P. Medicinal mushrooms: Towards a new horizon. Pharmacogn. Rev. 2010, 4, 127–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chaturvedi, V.K.; Agarwal, S.; Gupta, K.K.; Ramteke, P.W.; Singh, M.P. Medicinal mushroom: Boon for therapeutic applications. Biotech 2018, 8, 334. [Google Scholar] [CrossRef] [PubMed]
- Hetland, G.; Johnson, E.; Bernardshaw, S.V.; Grinde, B. Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation? Scand. J. Immunol. 2021, 93, e12937. [Google Scholar] [CrossRef] [PubMed]
- Arunachalam, K.; Sasidharan, S.P.; Yang, X. A concise review of mushrooms antiviral and immunomodulatory properties that may combat against COVID-19. Food Chem. Adv. 2022, 1, 100023. [Google Scholar] [CrossRef]
- Slomski, A. Trials Test Mushrooms and Herbs as Anti-COVID-19 Agents. JAMA 2021, 326, 1997–1999. [Google Scholar] [CrossRef] [PubMed]
- Donoso, A.; González-Durán, J.; Muñoz, A.A.; González, P.A.; Agurto-Muñoz, C. Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials. Pharmacol. Res. 2021, 166, 105479. [Google Scholar] [CrossRef] [PubMed]
- Higuera-Ciapara, I.; Félix-Valenzuela, L.; Goycoolea, F.M. Astaxanthin: A review of its chemistry and applications. Crit. Rev. Food Sci. Nutr. 2006, 46, 185–196. [Google Scholar] [CrossRef] [PubMed]
- Brotosudarmo, T.H.P.; Limantara, L.; Setiyono, E.; Heriyanto. Structures of Astaxanthin and Their Consequences for Therapeutic Application. Int. J. Food Sci. 2020, 2020, 2156582. [Google Scholar] [CrossRef]
- Ambati, R.R.; Phang, S.M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications—A review. Mar. Drugs 2014, 12, 128–152. [Google Scholar] [CrossRef] [PubMed]
- Fakhri, S.; Abbaszadeh, F.; Dargahi, L.; Jorjani, M. Astaxanthin: A mechanistic review on its biological activities and health benefits. Pharmacol. Res. 2018, 136, 1–20. [Google Scholar] [CrossRef]
- Kang, H.; Kim, H. Astaxanthin and β-carotene in Helicobacter pylori-induced Gastric Inflammation: A Mini-review on Action Mechanisms. J. Cancer Prev. 2017, 22, 57–61. [Google Scholar] [CrossRef] [Green Version]
- Talukdar, J.; Bhadra, B.; Dattaroy, T.; Nagle, V.; Dasgupta, S. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19. Biomed. Pharmacother. 2020, 132, 110886. [Google Scholar] [CrossRef] [PubMed]
- Ahmadi, A.R.; Ayazi-Nasrabadi, R. Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19. Iran. J. Microbiol. 2021, 13, 434–441. [Google Scholar] [CrossRef]
- Sivarajan, R.; Oberwinkler, H.; Roll, V.; König, E.M.; Steinke, M.; Bodem, J. A defined anthocyanin mixture sourced from bilberry and black currant inhibits Measles virus and various herpesviruses. BMC Complement. Med. Ther. 2022, 22, 181. [Google Scholar] [CrossRef]
- Akbar, S. Andrographis paniculata: A review of pharmacological activities and clinical effects. Altern. Med. Rev. 2011, 16, 66–77. [Google Scholar]
- Dai, Y.; Chen, S.R.; Chai, L.; Zhao, J.; Wang, Y.; Wang, Y. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit. Rev. Food Sci. Nutr. 2019, 59 (Suppl. 1), S17–S29. [Google Scholar] [CrossRef]
- Naomi, R.; Bahari, H.; Ong, Z.Y.; Keong, Y.Y.; Embong, H.; Rajandram, R.; Teoh, S.H.; Othman, F.; Hasham, R.; Yin, K.B.; et al. Mechanisms of Natural Extracts of Andrographis paniculata That Target Lipid-Dependent Cancer Pathways: A View from the Signaling Pathway. Int. J. Mol. Sci. 2022, 23, 5972. [Google Scholar] [CrossRef]
- Lu, J.; Ma, Y.; Wu, J.; Huang, H.; Wang, X.; Chen, Z.; Chen, J.; He, H.; Huang, C. A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed. Pharmacother. 2019, 117, 109078. [Google Scholar] [CrossRef] [PubMed]
- Islam, M.T. Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome. Front. Pharmacol. 2017, 8, 571. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stopponi, S.; Fotio, Y.; Cifani, C.; Li, H.; Haass-Koffler, C.L.; Cannella, N.; Demopulos, G.; Gaitanaris, G.; Ciccocioppo, R. Andrographis paniculata and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway. Alcohol Alcohol. 2021, 56, 240–249. [Google Scholar] [CrossRef] [PubMed]
- Sa-ngiamsuntorn, K.; Suksatu, A.; Pewkliang, Y.; Thongsri, P.; Kanjanasirirat, P.; Manopwisedjaroen, S.; Charoensutthivarakul, S.; Wongtrakoongate, P.; Pitiporn, S.; Chaopreecha, J.; et al. Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives. J. Nat. Prod. 2021, 84, 1261–1270. [Google Scholar] [CrossRef] [PubMed]
- Intharuksa, A.; Arunotayanun, W.; Yooin, W.; Sirisa-Ard, P. A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery. Molecules 2022, 27, 4479. [Google Scholar] [CrossRef] [PubMed]
- Kuropatnicki, A.K.; Szliszka, E.; Krol, W. Historical aspects of propolis research in modern times. Evid. Based Complement. Alternat. Med. 2013, 2013, 964149. [Google Scholar] [CrossRef] [Green Version]
- da Silva Barboza, A.; Aitken-Saavedra, J.P.; Ferreira, M.L.; Fábio Aranha, A.M.; Lund, R.G. Are propolis extracts potential pharmacological agents in human oral health?—A scoping review and technology prospecting. J. Ethnopharmacol. 2021, 271, 113846. [Google Scholar] [CrossRef]
- Almuhayawi, M.S. Propolis as a novel antibacterial agent. Saudi J. Biol. Sci. 2020, 27, 3079–3086. [Google Scholar] [CrossRef] [PubMed]
- Berretta, A.A.; Silveira, M.; Cóndor Capcha, J.M.; De Jong, D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed. Pharmacother. 2020, 131, 110622. [Google Scholar] [CrossRef]
- Dilokthornsakul, W.; Kosiyaporn, R.; Wuttipongwaragon, R.; Dilokthornsakul, P. Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies. J. Integr. Med. 2022, 20, 114–125. [Google Scholar] [CrossRef]
- Maruta, H.; He, H. PAK1-blockers: Potential Therapeutics against COVID-19. Med. Drug Discov. 2020, 6, 100039. [Google Scholar] [CrossRef]
- Williams, N.T. Probiotics. Am. J. Health Syst. Pharm. 2010, 67, 449–458. [Google Scholar] [CrossRef] [PubMed]
- Shi, L.H.; Balakrishnan, K.; Thiagarajah, K.; Mohd Ismail, N.I.; Yin, O.S. Beneficial Properties of Probiotics. Trop. Life Sci. Res. 2016, 27, 73–90. [Google Scholar] [CrossRef]
- Plaza-Diaz, J.; Ruiz-Ojeda, F.J.; Gil-Campos, M.; Gil, A. Mechanisms of Action of Probiotics. Adv. Nutr. 2020, 11 (Suppl. 1), S49–S66, published correction appears in Adv. Nutr. 2020, 11, 1054. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Antunes, A.E.C.; Vinderola, G.; Xavier-Santos, D.; Sivieri, K. Potential contribution of beneficial microbes to face the COVID-19 pandemic. Food Res. Int. 2020, 136, 109577. [Google Scholar] [CrossRef] [PubMed]
- Bottari, B.; Castellone, V.; Neviani, E. Probiotics and COVID-19. Int. J. Food Sci. Nutr. 2021, 72, 293–299. [Google Scholar] [CrossRef]
- Gutiérrez-Castrellón, P.; Gandara-Martí, T.; Abreu, Y.; Abreu, A.T.; Nieto-Rufino, C.D.; López-Orduña, E.; Jiménez-Escobar, I.; Jiménez-Gutiérrez, C.; López-Velazquez, G.; Espadaler-Mazo, J. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: A randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes 2022, 14, 2018899. [Google Scholar] [CrossRef] [PubMed]
- Tenório, M.C.D.S.; Graciliano, N.G.; Moura, F.A.; Oliveira, A.C.M.; Goulart, M.O.F. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants 2021, 10, 967. [Google Scholar] [CrossRef] [PubMed]
- Papi, A.; Di Stefano, A.F.D.; Radicioni, M. Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study. Adv. Ther. 2021, 38, 468–478. [Google Scholar] [CrossRef]
- Lu, S.C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830, 3143–3153. [Google Scholar] [CrossRef] [Green Version]
- Dodd, S.; Dean, O.; Copolov, D.L.; Malhi, G.S.; Berk, M. N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility. Expert Opin. Biol. Ther. 2008, 8, 1955–1962. [Google Scholar] [CrossRef]
- Mokhtari, V.; Afsharian, P.; Shahhoseini, M.; Kalantar, S.M.; Moini, A. A Review on Various Uses of N-Acetyl Cysteine. Cell J. 2017, 19, 11–17. [Google Scholar] [CrossRef]
- Schwalfenberg, G.K. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). J. Nutr. Metab. 2021, 2021, 9949453. [Google Scholar] [CrossRef]
- Wong, K.K.; Lee, S.; Kua, K.P. N-Acetylcysteine as Adjuvant Therapy for COVID-19—A Perspective on the Current State of the Evidence. J. Inflamm. Res. 2021, 14, 2993–3013. [Google Scholar] [CrossRef] [PubMed]
- Mohanty, R.R.; Padhy, B.M.; Das, S.; Meher, B.R. Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: Review of current evidence. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 2802–2807. [Google Scholar] [CrossRef] [PubMed]
- Izquierdo, J.L.; Soriano, J.B.; González, Y.; Lumbreras, S.; Ancochea, J.; Echeverry, C.; Rodríguez, J.M. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19. Sci. Prog. 2022, 105, 368504221074574. [Google Scholar] [CrossRef]
- Sanchez-Gonzalez, M.A.; Moskowitz, D.; Issuree, P.D.; Yatzkan, G.; Rizvi, S.A.A.; Day, K. A Pathophysiological Perspective on COVID-19’s Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation. Infect. Chemother. 2020, 52, 335–344. [Google Scholar] [CrossRef] [PubMed]
- Yang, D.; Wang, T.; Long, M.; Li, P. Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine. Oxid. Med. Cell Longev. 2020, 2020, 8825387. [Google Scholar] [CrossRef] [PubMed]
- Batiha, G.E.; Beshbishy, A.M.; Ikram, M.; Mulla, Z.S.; El-Hack, M.E.A.; Taha, A.E.; Algammal, A.M.; Elewa, Y.H.A. The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin. Foods 2020, 9, 374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Muñoz-Reyes, D.; Morales, A.I.; Prieto, M. Transit and Metabolic Pathways of Quercetin in Tubular Cells: Involvement of Its Antioxidant Properties in the Kidney. Antioxidants 2021, 10, 909. [Google Scholar] [CrossRef]
- Di Petrillo, A.; Orrù, G.; Fais, A.; Fantini, M.C. Quercetin and its derivates as antiviral potentials: A comprehensive review. Phytother. Res. 2022, 36, 266–278. [Google Scholar] [CrossRef]
- Manjunath, S.H.; Thimmulappa, R.K. Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19. J. Pharm. Anal. 2022, 12, 29–34. [Google Scholar] [CrossRef]
- Imran, M.; Thabet, H.K.; Alaqel, S.I.; Alzahrani, A.R.; Abida, A.; Alshammari, M.K.; Kamal, M.; Diwan, A.; Asdaq, S.M.B.; Alshehri, S. The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. Antioxidants 2022, 11, 876. [Google Scholar] [CrossRef]
- Munafò, F.; Donati, E.; Brindani, N.; Ottonello, G.; Armirotti, A.; De Vivo, M. Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci. Rep. 2022, 12, 10571. [Google Scholar] [CrossRef] [PubMed]
- Aucoin, M.; Cooley, K.; Saunders, P.R.; Cardozo, V.; Remy, D.; Cramer, H.; Abad, C.N.; Hannan, N. The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review. Adv. Integr. Med. 2020, 7, 247–251. [Google Scholar] [CrossRef] [PubMed]
- Bahoosh, S.R.; Shokoohinia, Y.; Eftekhari, M. Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2. Daru 2022, 30, 245–252. [Google Scholar] [CrossRef] [PubMed]
- Jia, H.; Zhang, Y.; Si, X.; Jin, Y.; Jiang, D.; Dai, Z.; Wu, Z. Quercetin Alleviates Oxidative Damage by Activating Nuclear Factor Erythroid 2-Related Factor 2 Signaling in Porcine Enterocytes. Nutrients 2021, 13, 375. [Google Scholar] [CrossRef] [PubMed]
- Yi, L.; Li, Z.; Yuan, K.; Qu, X.; Chen, J.; Wang, G.; Zhang, H.; Luo, H.; Zhu, L.; Jiang, P.; et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004, 78, 11334–11339. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Catalano, A.; Iacopetta, D.; Ceramella, J.; Maio, A.C.; Basile, G.; Giuzio, F.; Bonomo, M.G.; Aquaro, S.; Walsh, T.J.; Sinicropi, M.S.; et al. Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment? Foods 2022, 11, 2884. [Google Scholar] [CrossRef]
- Verna, G.; Liso, M.; Cavalcanti, E.; Bianco, G.; Di Sarno, V.; Santino, A.; Campiglia, P.; Chieppa, M. Quercetin Administration Suppresses the Cytokine Storm in Myeloid and Plasmacytoid Dendritic Cells. Int. J. Mol. Sci. 2021, 22, 8349. [Google Scholar] [CrossRef]
- Alshrari, A.S.; Hudu, S.A.; Imran, M.; Asdaq, S.M.B.; Ali, A.M.; Rabbani, S.I. Innovations and development of COVID-19 vaccines: A patent review. J. Infect. Public Health 2022, 15, 123–131. [Google Scholar] [CrossRef]
- Mouffouk, C.; Mouffouk, S.; Mouffouk, S.; Hambaba, L.; Haba, H. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). Eur. J. Pharmacol. 2021, 891, 173759. [Google Scholar] [CrossRef]
- Pawar, A.; Russo, M.; Rani, I.; Goswami, K.; Russo, G.L.; Pal, A. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions. Phytother. Res. 2022, 36, 2394–2415. [Google Scholar] [CrossRef]
- Khan, A.; Iqtadar, S.; Mumtaz, S.U.; Heinrich, M.; Pascual-Figal, D.A.; Livingstone, S.; Abaidullah, S. Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial. Front Pharmacol 2022, 13, 898062. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rizvi, S.A.A.; Einstein, G.P.; Tulp, O.L.; Sainvil, F.; Branly, R. Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases. Biomolecules 2022, 12, 1442. https://doi.org/10.3390/biom12101442
Rizvi SAA, Einstein GP, Tulp OL, Sainvil F, Branly R. Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases. Biomolecules. 2022; 12(10):1442. https://doi.org/10.3390/biom12101442
Chicago/Turabian StyleRizvi, Syed A. A., George P. Einstein, Orien L. Tulp, Frantz Sainvil, and Rolando Branly. 2022. "Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases" Biomolecules 12, no. 10: 1442. https://doi.org/10.3390/biom12101442
APA StyleRizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022). Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases. Biomolecules, 12(10), 1442. https://doi.org/10.3390/biom12101442